EGFR and erbB2 mutation status in Japanese lung cancer patients-Reference-Cited by-同舟云学术

EGFR and erbB2 mutation status in Japanese lung cancer patients

Published:2005 Issue:1 Volume:118 Page:180-184
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Sasaki Hidefumi,Shimizu Shigeki,Endo Katsuhiko,Takada Minoru,Kawahara Masaaki,Tanaka Hisaichi,Matsumura Akihide,Iuchi Keiji,Haneda Hiroshi,Suzuki Eriko,Kobayashi Yoshihiro,Yano Motoki,Fujii Yoshitaka

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. , . Cancer of the lung. In: Principles and practice of oncology, 4th ed. Philadelphia: Lippincott, 1993. 673-82.

2. Thoracic and cardiovascular surgery in Japan during 1998

3. Chemotherapy for Non-small Cell Lung Cancer

4. EGFR and cancer prognosis

5. Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers;Onco;2023-05-26

2. An Anti-EGFR/anti- HER2 Bispecific Antibody with Enhanced Antitumor Activity Against Acquired Gefitinib-Resistant NSCLC Cells;Protein & Peptide Letters;2021-11

3. Inference for High-Dimensional Censored Quantile Regression;Journal of the American Statistical Association;2021-08-20

4. Screening of significant oncogenic changes in air pollution-related lung cancer in Chinese population;Translational Cancer Research;2020-07

5. Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma;Translational Lung Cancer Research;2020-06